TreeWAS – Variant ID: rs10507380

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C17.0 Duodenum	0.023	0.977	0.000
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge	0.023	0.977	0.000
C17 Malignant neoplasm of small intestine	0.022	0.978	0.000
C16.0 Cardia	0.022	0.978	0.000
C16 Malignant neoplasm of stomach	0.022	0.978	0.000
C16.9 Stomach, unspecified	0.021	0.979	0.000
K06 Other disorders of gingiva and edentulous alveolar ridge	0.021	0.979	0.000
C17.2 Ileum	0.020	0.980	0.000
C16.6 Greater curvature of stomach, unspecified	0.019	0.981	0.000
C15-C26 Malignant neoplasms of digestive organs	0.018	0.982	0.000
K06.1 Gingival enlargement	0.018	0.982	0.000
C17.1 Jejunum	0.017	0.983	0.000
K06.2 Gingival and edentulous alveolar ridge lesions associated with trauma	0.017	0.983	0.000
C17.9 Small intestine, unspecified	0.017	0.983	0.000
K14 Diseases of tongue	0.017	0.983	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.017	0.983	0.000
K00-K14 Diseases of oral cavity, salivary glands and jaws	0.017	0.983	0.000
C16.3 Pyloric antrum	0.016	0.984	0.000
K08.9 Disorder of teeth and supporting structures, unspecified	0.016	0.984	0.000
C17.8 Overlapping lesion of small intestine	0.016	0.984	0.000
C17.3 Meckel's diverticulum	0.016	0.984	0.000
C16.8 Overlapping lesion of stomach	0.016	0.984	0.000
C16.4 Pylorus	0.016	0.984	0.000
C16.1 Fundus of stomach	0.016	0.984	0.000
C16.2 Body of stomach	0.016	0.984	0.000
C44.6 Skin of upper limb, including shoulder	0.016	0.984	0.000
K14.8 Other diseases of tongue	0.016	0.984	0.000
K08 Other disorders of teeth and supporting structures	0.016	0.984	0.000
K14.0 Glossitis	0.015	0.985	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.015	0.985	0.000
C24.1 Ampulla of Vater	0.015	0.985	0.000
K06.0 Gingival recession	0.015	0.985	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.015	0.985	0.000
C15 Malignant neoplasm of oesophagus	0.015	0.985	0.000
K10 Other diseases of jaws	0.015	0.985	0.000
K05 Gingivitis and periodontal diseases	0.014	0.986	0.000
K00 Disorders of tooth development and eruption	0.014	0.986	0.000
K01 Embedded and impacted teeth	0.013	0.987	0.000
C24.9 Biliary tract, unspecified	0.013	0.987	0.000
C15.5 Lower third of oesophagus	0.013	0.987	0.000
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified	0.013	0.987	0.000
K08.2 Atrophy of edentulous alveolar ridge	0.013	0.987	0.000
K12 Stomatitis and related lesions	0.013	0.987	0.000
C21 Malignant neoplasm of anus and anal canal	0.012	0.987	0.000
K14.9 Disease of tongue, unspecified	0.013	0.987	0.000
M35.3 Polymyalgia rheumatica	0.000	0.988	0.012
K14.6 Glossodynia	0.012	0.988	0.000
K14.5 Plicated tongue	0.012	0.988	0.000
K14.4 Atrophy of tongue papillae	0.012	0.988	0.000
K14.3 Hypertrophy of tongue papillae	0.012	0.988	0.000
K14.2 Median rhomboid glossitis	0.012	0.988	0.000
K14.1 Geographic tongue	0.012	0.988	0.000
K10.3 Alveolitis of jaws	0.012	0.988	0.000
K10.0 Developmental disorders of jaws	0.012	0.988	0.000
C23 Malignant neoplasm of gallbladder	0.012	0.988	0.000
K13 Other diseases of lip and oral mucosa	0.012	0.988	0.000
C24.8 Overlapping lesion of biliary tract	0.012	0.988	0.000
C16.5 Lesser curvature of stomach, unspecified	0.012	0.988	0.000
K05.6 Periodontal disease, unspecified	0.012	0.988	0.000
K03 Other diseases of hard tissues of teeth	0.012	0.988	0.000
K13.0 Diseases of lips	0.012	0.988	0.000
C24.0 Extrahepatic bile duct	0.011	0.988	0.000
K00.6 Disturbances in tooth eruption	0.012	0.988	0.000
K08.0 Exfoliation of teeth due to systemic causes	0.011	0.989	0.000
C26.9 Ill-defined sites within the digestive system	0.011	0.989	0.000
K05.3 Chronic periodontitis	0.011	0.989	0.000
K11 Diseases of salivary glands	0.011	0.989	0.000
C26.0 Intestinal tract, part unspecified	0.011	0.989	0.000
K08.8 Other specified disorders of teeth and supporting structures	0.011	0.989	0.000
K01.1 Impacted teeth	0.011	0.989	0.000
K10.2 Inflammatory conditions of jaws	0.011	0.989	0.000
C26.8 Overlapping lesion of digestive system	0.011	0.989	0.000
C26.1 Spleen	0.011	0.989	0.000
C15.8 Overlapping lesion of oesophagus	0.011	0.989	0.000
C15.2 Abdominal part of oesophagus	0.011	0.989	0.000
C15.1 Thoracic part of oesophagus	0.011	0.989	0.000
C15.0 Cervical part of oesophagus	0.011	0.989	0.000
K10.9 Disease of jaws, unspecified	0.011	0.989	0.000
K10.1 Giant cell granuloma, central	0.011	0.989	0.000
K12.1 Other forms of stomatitis	0.011	0.989	0.000
K08.1 Loss of teeth due to accident, extraction or local periodontal disease	0.011	0.989	0.000
C15.4 Middle third of oesophagus	0.010	0.989	0.000
C18 Malignant neoplasm of colon	0.010	0.990	0.000
C15.3 Upper third of oesophagus	0.010	0.990	0.000
K09 Cysts of oral region, not elsewhere classified	0.010	0.990	0.000
K05.2 Acute periodontitis	0.010	0.990	0.000
K05.5 Other periodontal diseases	0.010	0.990	0.000
K05.4 Periodontosis	0.010	0.990	0.000
K05.0 Acute gingivitis	0.010	0.990	0.000
K01.0 Embedded teeth	0.010	0.990	0.000
K00.9 Disorder of tooth development, unspecified	0.010	0.990	0.000
K00.8 Other disorders of tooth development	0.010	0.990	0.000
K00.7 Teething syndrome	0.010	0.990	0.000
K00.5 Hereditary disturbances in tooth structure, not elsewhere classified	0.010	0.990	0.000
K00.4 Disturbances in tooth formation	0.010	0.990	0.000
K00.3 Mottled teeth	0.010	0.990	0.000
K00.2 Abnormalities of size and form of teeth	0.010	0.990	0.000
K00.1 Supernumerary teeth	0.010	0.990	0.000
K00.0 Anodontia	0.010	0.990	0.000
K10.8 Other specified diseases of jaws	0.010	0.990	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.010	0.990	0.000
K11.1 Hypertrophy of salivary gland	0.010	0.990	0.000
C18.5 Splenic flexure	0.009	0.990	0.000
C21.1 Anal canal	0.009	0.991	0.000
K05.1 Chronic gingivitis	0.009	0.991	0.000
C21.2 Cloacogenic zone	0.009	0.991	0.000
C25 Malignant neoplasm of pancreas	0.009	0.991	0.000
C18.2 Ascending colon	0.009	0.991	0.000
K12.2 Cellulitis and abscess of mouth	0.009	0.991	0.000
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue	0.009	0.991	0.000
K13.5 Oral submucous fibrosis	0.009	0.991	0.000
K13.3 Hairy leukoplakia	0.009	0.991	0.000
K13.1 Cheek and lip biting	0.009	0.991	0.000
K03.9 Disease of hard tissues of teeth, unspecified	0.009	0.991	0.000
K03.8 Other specified diseases of hard tissues of teeth	0.009	0.991	0.000
K03.7 Posteruptive colour changes of dental hard tissues	0.009	0.991	0.000
K03.6 Deposits [accretions] on teeth	0.009	0.991	0.000
K03.5 Ankylosis of teeth	0.009	0.991	0.000
K03.4 Hypercementosis	0.009	0.991	0.000
K03.3 Pathological resorption of teeth	0.009	0.991	0.000
K03.2 Erosion of teeth	0.009	0.991	0.000
K03.1 Abrasion of teeth	0.009	0.991	0.000
K03.0 Excessive attrition of teeth	0.009	0.991	0.000
K12.3 Oral mucositis (ulcerative)	0.009	0.991	0.000
T43.2 Other and unspecified antidepressants	0.000	0.991	0.009
K11.3 Abscess of salivary gland	0.009	0.991	0.000
K09.9 Cyst of oral region, unspecified	0.009	0.991	0.000
K11.7 Disturbances of salivary secretion	0.008	0.991	0.000
C15.9 Oesophagus, unspecified	0.009	0.991	0.000
K12.0 Recurrent oral aphthae	0.008	0.991	0.000
K11.4 Fistula of salivary gland	0.008	0.992	0.000
K11.0 Atrophy of salivary gland	0.008	0.992	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.992	0.008
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.992	0.008
C18.6 Descending colon	0.008	0.992	0.000
K11.5 Sialolithiasis	0.008	0.992	0.000
C18.4 Transverse colon	0.008	0.992	0.000
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.008	0.992	0.000
K13.4 Granuloma and granuloma-like lesions of oral mucosa	0.008	0.992	0.000
K22.7 Barrett's oesophagus	0.008	0.992	0.000
K09.1 Developmental (nonodontogenic) cysts of oral region	0.008	0.992	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.008	0.992	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.008	0.992	0.000
K11.6 Mucocele of salivary gland	0.008	0.992	0.000
K11.2 Sialoadenitis	0.008	0.992	0.000
C18.8 Overlapping lesion of colon	0.008	0.992	0.000
K11.9 Disease of salivary gland, unspecified	0.008	0.992	0.000
K05.22 Aggressive periodontitis, generalized	0.007	0.992	0.000
K09.8 Other cysts of oral region, not elsewhere classified	0.008	0.992	0.000
C25.3 Pancreatic duct	0.007	0.992	0.000
C25.7 Other parts of pancreas	0.007	0.993	0.000
C21.0 Anus, unspecified	0.007	0.993	0.000
K07 Dentofacial anomalies [including malocclusion]	0.006	0.993	0.001
C18.3 Hepatic flexure	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.993	0.007
C25.8 Overlapping lesion of pancreas	0.007	0.993	0.000
C25.4 Endocrine pancreas	0.007	0.993	0.000
H50.1 Divergent concomitant strabismus	0.000	0.993	0.007
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.993	0.007
K13.29 Other disturbances of oral epithelium, including tongue	0.007	0.993	0.000
C18.9 Colon, unspecified	0.007	0.993	0.000
K11.8 Other diseases of salivary glands	0.007	0.993	0.000
C25.1 Body of pancreas	0.006	0.994	0.000
K09.2 Other cysts of jaw	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.994	0.006
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.994	0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.994	0.006
C25.2 Tail of pancreas	0.006	0.994	0.000
K08.3 Retained dental root	0.006	0.994	0.000
K13.6 Irritative hyperplasia of oral mucosa	0.006	0.994	0.000
C18.1 Appendix	0.006	0.994	0.000
C25.0 Head of pancreas	0.006	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.994	0.006
C22.7 Other specified carcinomas of liver	0.006	0.994	0.000
C22.4 Other sarcomas of liver	0.006	0.994	0.000
C22.3 Angiosarcoma of liver	0.006	0.994	0.000
C22.2 Hepatoblastoma	0.006	0.994	0.000
C22.1 Intrahepatic bile duct carcinoma	0.006	0.994	0.000
H50 Other strabismus	0.000	0.994	0.006
K02 Dental caries	0.006	0.994	0.000
H50.9 Strabismus, unspecified	0.000	0.994	0.006
T43.6 Psychostimulants with abuse potential	0.000	0.994	0.006
K07.9 Dentofacial anomaly, unspecified	0.005	0.994	0.001
K09.0 Developmental odontogenic cysts	0.005	0.994	0.000
M54.22 Cervicalgia (Cervical region)	0.000	0.994	0.006
C20 Malignant neoplasm of rectum	0.006	0.994	0.000
K07.2 Anomalies of dental arch relationship	0.005	0.994	0.001
K07.8 Other dentofacial anomalies	0.005	0.995	0.001
K07.5 Dentofacial functional abnormalities	0.005	0.995	0.001
K07.0 Major anomalies of jaw size	0.005	0.995	0.001
H02.3 Blepharochalasis	0.005	0.995	0.000
K07.4 Malocclusion, unspecified	0.004	0.995	0.001
H50.0 Convergent concomitant strabismus	0.000	0.995	0.005
K02.1 Caries of dentin	0.005	0.995	0.000
C18.7 Sigmoid colon	0.005	0.995	0.000
K07.6 Temporomandibular joint disorders	0.004	0.995	0.001
H50.5 Heterophoria	0.000	0.995	0.005
K07.1 Anomalies of jaw-cranial base relationship	0.004	0.995	0.001
H50.8 Other specified strabismus	0.000	0.995	0.004
H50.6 Mechanical strabismus	0.000	0.995	0.004
H50.4 Other and unspecified heterotropia	0.000	0.995	0.004
H50.3 Intermittent heterotropia	0.000	0.995	0.004
K02.5 Caries with pulp exposure	0.004	0.995	0.000
K02.4 Odontoclasia	0.004	0.995	0.000
K02.3 Arrested dental caries	0.004	0.995	0.000
K02.2 Caries of cementum	0.004	0.995	0.000
K02.0 Caries limited to enamel	0.004	0.995	0.000
C22.9 Liver, unspecified	0.004	0.996	0.000
K07.3 Anomalies of tooth position	0.001	0.996	0.003
T42.4 Benzodiazepines	0.000	0.996	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.996	0.004
H50.2 Vertical strabismus	0.000	0.996	0.004
M54.29 Cervicalgia-Site unspe	0.000	0.996	0.004
I80 Phlebitis and thrombophlebitis	0.004	0.996	0.000
M54.2 Cervicalgia	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
C22.0 Liver cell carcinoma	0.003	0.996	0.001
R17 Unspecified jaundice	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.996	0.004
S92.10 Fracture of talus (closed)	0.004	0.996	0.000
C25.9 Pancreas, unspecified	0.003	0.996	0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.004	0.996	0.000
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.003	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.997	0.003
S92.1 Fracture of talus	0.003	0.997	0.000
K02.8 Other dental caries	0.003	0.997	0.000
T40.4 Other synthetic narcotics	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.997	0.003
M54.27 Cervicalgia-Lumbosacral	0.000	0.997	0.003
M54.26 Cervicalgia-Lumbar	0.000	0.997	0.003
M54.25 Cervicalgia-Thoracolumbar	0.000	0.997	0.003
M54.24 Cervicalgia-Thoracic	0.000	0.997	0.003
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.997	0.003
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.997	0.003
M54.20 Cervicalgia-Mult site	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.003
Z45.8 Adjustment and management of other implanted devices	0.003	0.997	0.000
S92.00 Fracture of calcaneus (closed)	0.003	0.997	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.003	0.997	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
S92.0 Fracture of calcaneus	0.003	0.997	0.000
S92 Fracture of foot, except ankle	0.003	0.997	0.000
C18.0 Caecum	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.002
T36.8 Other systemic antibiotics	0.000	0.997	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
T36.6 Rifamycins	0.000	0.997	0.002
T36.5 Aminoglycosides	0.000	0.997	0.002
T36.4 Tetracyclines	0.000	0.997	0.002
T36.3 Macrolides	0.000	0.997	0.002
T36.2 Chloramphenicol group	0.000	0.997	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.002
T36.0 Penicillins	0.000	0.997	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T37.5 Antiviral drugs	0.000	0.997	0.002
T37.4 Anthelminthics	0.000	0.997	0.002
T37.3 Other antiprotozoal drugs	0.000	0.997	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.002
T37.1 Antimycobacterial drugs	0.000	0.997	0.002
T37.0 Sulphonamides	0.000	0.997	0.002
T41.5 Therapeutic gases	0.000	0.997	0.002
T41.4 Anaesthetic, unspecified	0.000	0.997	0.002
T41.3 Local anaesthetics	0.000	0.997	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
T41.1 Intravenous anaesthetics	0.000	0.997	0.002
T41.0 Inhaled anaesthetics	0.000	0.997	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.002
T48.5 Anti-common-cold drugs	0.000	0.997	0.002
T48.4 Expectorants	0.000	0.997	0.002
T48.3 Antitussives	0.000	0.997	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.002
T48.0 Oxytocic drugs	0.000	0.997	0.002
T49.9 Topical agent, unspecified	0.000	0.997	0.002
T49.8 Other topical agents	0.000	0.997	0.002
T49.7 Dental drugs, topically applied	0.000	0.997	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.002
T49.2 Local astringents and local detergents	0.000	0.997	0.002
T49.1 Antipruritics	0.000	0.997	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
T47.7 Emetics	0.000	0.997	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.002
T47.5 Digestants	0.000	0.997	0.002
T47.4 Other laxatives	0.000	0.997	0.002
T47.3 Saline and osmotic laxatives	0.000	0.997	0.002
T47.2 Stimulant laxatives	0.000	0.997	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.002
W07.0 Home	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.002
E04.9 Non-toxic goitre, unspecified	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.002
S92.11 Fracture of talus (open)	0.002	0.997	0.000
S92.2 Fracture of other tarsal bone(s)	0.002	0.997	0.000
I80.8 Phlebitis and thrombophlebitis of other sites	0.002	0.997	0.000
T50.8 Diagnostic agents	0.000	0.997	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.002
T50.5 Appetite depressants	0.000	0.997	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.002
S92.3 Fracture of metatarsal bone	0.002	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.002
T39.2 Pyrazolone derivatives	0.000	0.997	0.002
N86 Erosion and ectropion of cervix uteri	0.003	0.997	0.000
S92.7 Multiple fractures of foot	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
Z11 Special screening examination for infectious and parasitic diseases	0.000	0.998	0.002
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.998	0.000
Q87.4 Marfan's syndrome	0.002	0.998	0.000
R82 Other abnormal findings in urine	0.000	0.998	0.002
Z11.5 Special screening examination for other viral diseases	0.000	0.998	0.002
Z11.2 Special screening examination for other bacterial diseases	0.000	0.998	0.002
S92.01 Fracture of calcaneus (open)	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
S92.70 Multiple fractures of foot (closed)	0.002	0.998	0.000
S92.9 Fracture of foot, unspecified	0.002	0.998	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.000	0.998	0.002
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.002	0.998	0.000
S92.4 Fracture of great toe	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.000	0.998	0.002
R82.7 Abnormal findings on microbiological examination of urine	0.000	0.998	0.002
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.998	0.002
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.002	0.998	0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.998	0.002
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.000	0.998	0.002
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.998	0.002
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.002	0.998	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
T90.2 Sequelae of fracture of skull and facial bones	0.000	0.998	0.002
S92.31 Fracture of metatarsal bone (open)	0.002	0.998	0.000
S92.71 Multiple fractures of foot (open)	0.002	0.998	0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.002	0.998	0.000
S92.5 Fracture of other toe	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.000	0.998	0.002
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.002	0.998	0.000
Z11.8 Special screening examination for other infectious and parasitic diseases	0.000	0.998	0.002
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.000	0.998	0.002
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.000	0.998	0.002
Z11.1 Special screening examination for respiratory tuberculosis	0.000	0.998	0.002
Q80-Q89 Other congenital malformations	0.002	0.998	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.002	0.998	0.000
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.000	0.998	0.002
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
K37 Unspecified appendicitis	0.002	0.998	0.000
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.002	0.998	0.000
N92.6 Irregular menstruation, unspecified	0.002	0.998	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.998	0.002
R82.4 Acetonuria	0.000	0.998	0.002
R82.3 Haemoglobinuria	0.000	0.998	0.002
R82.2 Biliuria	0.000	0.998	0.002
R82.1 Myoglobinuria	0.000	0.998	0.002
R82.0 Chyluria	0.000	0.998	0.002
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
Q89 Other congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q89.2 Congenital malformations of other endocrine glands	0.002	0.998	0.000
S92.41 Fracture of great toe (open)	0.002	0.998	0.000
S92.91 Fracture of foot, unspecified (open)	0.002	0.998	0.000
S92.90 Fracture of foot, unspecified (closed)	0.002	0.998	0.000
Q51.3 Bicornate uterus	0.002	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.002	0.998	0.000
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.002	0.998	0.000
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.002	0.998	0.000
Q87.3 Congenital malformation syndromes involving early overgrowth	0.002	0.998	0.000
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.002	0.998	0.000
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.002	0.998	0.000
Q82 Other congenital malformations of skin	0.002	0.998	0.000
J15.0 Pneumonia due to Klebsiella pneumoniae	0.002	0.998	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.998	0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.002	0.998	0.000
Z42.1 Follow-up care involving plastic surgery of breast	0.002	0.998	0.000
M35 Other systemic involvement of connective tissue	0.000	0.998	0.002
S92.40 Fracture of great toe (closed)	0.002	0.998	0.000
Q54.0 Hypospadias, balanic	0.002	0.998	0.000
F31 Bipolar affective disorder	0.002	0.998	0.000
Q51 Congenital malformations of uterus and cervix	0.002	0.998	0.000
M14.6 Neuropathic arthropathy	0.002	0.998	0.000
N43.3 Hydrocele, unspecified	0.002	0.998	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.001
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.001
S82.40 Fracture of fibula alone (closed)	0.002	0.998	0.000
S92.51 Fracture of other toe (open)	0.001	0.998	0.000
Q82.2 Mastocytosis	0.002	0.998	0.000
Z13.3 Special screening examination for mental and behavioural disorders	0.002	0.998	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.002	0.998	0.000
Q51.2 Other doubling of uterus	0.002	0.998	0.000
Q54 Hypospadias	0.002	0.998	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.002	0.998	0.000
Q84 Other congenital malformations of integument	0.002	0.998	0.000
Q83 Congenital malformations of breast	0.002	0.998	0.000
Q81 Epidermolysis bullosa	0.002	0.998	0.000
Q80 Congenital ichthyosis	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
B17.1 Acute hepatitis C	0.000	0.998	0.002
Q82.5 Congenital nonneoplastic naevus	0.002	0.998	0.000
Q89.9 Congenital malformation, unspecified	0.001	0.998	0.000
Q89.8 Other specified congenital malformations	0.001	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.001	0.998	0.000
Q89.4 Conjoined twins	0.001	0.998	0.000
Q89.3 Situs inversus	0.001	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.001	0.998	0.000
Q89.0 Congenital malformations of spleen	0.001	0.998	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.002	0.998	0.000
K25.3 Acute without haemorrhage or perforation	0.002	0.998	0.000
Q82.8 Other specified congenital malformations of skin	0.002	0.998	0.000
Q85.9 Phakomatosis, unspecified	0.001	0.998	0.000
Q85.8 Other phakomatoses, not elsewhere classified	0.001	0.998	0.000
Q85.1 Tuberous sclerosis	0.001	0.998	0.000
Q82.9 Congenital malformation of skin, unspecified	0.001	0.998	0.000
Q82.4 Ectodermal dysplasia (anhidrotic)	0.001	0.998	0.000
Q82.3 Incontinentia pigmenti	0.001	0.998	0.000
Q82.1 Xeroderma pigmentosum	0.001	0.998	0.000
Q82.0 Hereditary lymphoedema	0.001	0.998	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.998	0.002
M81.98 Osteoporosis, unspecified (Other)	0.000	0.998	0.002
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.002	0.998	0.000
M35.9 Systemic involvement of connective tissue, unspecified	0.000	0.998	0.001
M35.8 Other specified systemic involvement of connective tissue	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations